About Resmetirom API

CH₃ H₃C-O N
Therapeutic Category Thyroid Hormone Receptor (THR) agonist
CAS Number 920509-32-6
API Technology Novel API Development
Dose Form Tablets / Capsules
Synergene's Development Status Under Development
Available Regulatory Filing Under Validation / Process Optimization

Mechanism of Action

Resmetirom is currently under laboratory validation and pilot process optimization for Thyroid Hormone Receptor (THR) agonist therapy.

Target Indication

Under development for Thyroid Hormone Receptor (THR) agonist indications. Scale-up batches in progress.